-
Is rapid HIV testing in use in your family planning facility? Findings from a 2007 survey conducted by the National Alliance of State and Territorial AIDS Directors Rapid point to "yes"; 94% of health departments indicated they use rapid HIV testing as part of health department-supported HIV testing programs.
-
-
Take a poll among your female patients about their preferences surrounding their menstrual cycle. How many would prefer to get their periods less often?
-
What is the most cost-effective approach to administering vaccination against human papillomavirus (HPV)? A just-released analysis concludes vaccination will be optimized by achieving universal vaccine coverage in young adolescent girls, targeting initial "catch-up" efforts to vaccinate women younger than age 21, and by revising current screening policies.
-
Review the last three patient charts: a 19-year-old college student, a 26-year-old mother of two, and a 43-year-old woman who is newly divorced. Which women were offered screening for HIV?
-
Concerns about the effects of the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City; Medroxyprogesterone Acetate Injectable Suspension USP, Teva Pharmaceuticals USA, North Wales, PA) on bone mineral density (BMD) should not prevent clinicians from prescribing the method, nor should its use be limited to two years, according to a new committee opinion released by the American College of Obstetricians and Gynecologists (ACOG).
-
-
The FDA has approved the first drug for the treatment of Huntington's disease.
-
Whereas racial concordance is the primary predictor of perceived ethnic similarity, patients do value higher communication skills, which may actually result in better outcomes.
-
In knee OA, arthroscopic surgery confers no benefit.